Bro ,
Going rates for Dr Sim Hong Gee not inexpensive , definitely not S$8/- , i heard , check this out
http://gleneagles.com.sg/DoctorsCV/Urology/Dr-Sim-Hong-Gee?speciality=UROLOGY
Specialty Urology
Clinics
Ravenna Urology Clinic Pte Ltd
6 Napier Road #07-12 Singapore 258499
Contact No: 64797822
Qualifications
MBBS, MRCSEd, MMED(Surgery), FAMS(Urology)
Languages
English, Chinese (Mandarin), Chinese dialects (Hokkien, Teochew, Cantonese), Bahasa Malayu
Clinical Focus
General Urology including benign prostate enlargement, urinary stones, urinary strictures and obstruction, male subfertility, incontinence and erectile dysfunction, urinary cancer assessment, biopsy and treatment (including prostate, bladder, kidney, adrenal, testicular and penile cancers), kidney transplant and pre-transplant urologic assessment
Background
Dr Sim obtained his medical degree from the National University of Singapore (NUS), his post-graduate surgical diploma from the Royal College of Surgeons of Edinburgh in UK and his Master in Medicine (Surgery) from the School of Post-graduate Medical Studies in NUS. He then completed his general urology training at the Department of Urology in Singapore General Hospital and was inducted as a fellow of the Academy of Medicine, Singapore.
Dr Sim was awarded and completed a 2-year Society of
Urologic Oncology fellowship in Seattle, Washington USA where he pursued further urology training in the management of kidney, bladder, prostate, testis and penile cancers. He was mentored by
Professor Paul H. Lange, Professor William J. Ellis and Associate professor Daniel W. Lin at the University of Washington Medical Centre and Professor Peter S. Nelson at the Fred Hutchinson Cancer Research Center. Dr Sim was the first urologist in Singapore and Southeast Asia to be certified by the Society of Urologic Oncology in the management of genito-urinary cancers.
Prior to his current practice,
Dr Sim was the
Director of Urologic Oncology at Singapore General Hospital and Director of Clinical database & outcomes research in Singhealth. He was an adjunct assistant professor of urology at Duke-NUS Graduate Medical School, clinical lecturer and MBBS examiner for Surgery track at the National University of Singapore Yong Loo Lin School of Medicine, and programme director for the Singhealth Urology residency training programme.
Dr Sim is recognised by his peers to be an expert in genito-urinary cancer surgery. He is conversant with open, laparoscopic and robot-assisted surgical approaches to cancer. He was involved in laparoscopic adrenal and kidney surgery since 2001 and was a key member of the original surgical team that started robotic radical prostatectomy revolution for early prostate cancer in Asia in 2002. He is certified by Intuitive Surgical Inc in Sunnyvale California, USA, to handle the robotic surgical system. In 2007, he introduced ultrasound guided peri-prostatic anaesthesia to minimise discomfort in men undergoing prostate biopsie and in 2009, he introduced robot-assisted partial nephrectomy for small kidney cancers in Singapore. In 2011, robot-assisted radical cystectomy was introduced.
In addition to complex cancer surgery,
Dr Sim also manages and treats benign prostate enlargement, urinary incontinence, male subfertility, pelvi-ureteric junction obstruction, ureteric and urethral strictures (narrowing of the urinary passages) and urinary stone disease using minimally invasive endoscopic, laparoscopic and robotic techniques. He is a gazetted kidney transplant surgeon and is frequently called upon by his peers to assist in urinary reconstruction in complex multi-disciplinary surgeries.
Dr Sim currently serves as
Chairman, Chapter of Urologists at the College of Surgeons, Academy of Medicine, Singapore, executive committee member of the Singapore Urological Association and the Secretary-General of the Asia-Pacific Society of Urologic Oncology. He is an advisory member of the Asian Society of Robotic Surgery and an active member of both the Singapore and American Urological Associations and the Society of Urologic Oncology (Chicago, Illinois, USA). He has research interests in genitourinary cancer, especially in prostate cancer biomarkers and cancer epigenetics and received research funding from National Medical Research Council (NMRC) and Singhealth Research Foundation. He was also a collaborator for many translational and clinical research studies involving multi-centre randomised controlled trials since 2001.
Dr Sim is a reviewer for NMRC grants and journal reviewer for various journals, including Annals of Academy of Medicine, Singapore, Urologic Oncology and Nature Clinical Practice in Urology and has published extensively on urinary cancers, laparoscopy, benign prostate enlargement, urinary obstruction and prostate biopsy technique, amongst others. He was the organising chairman for Singapore Urological Association (SUA) Live Surgery workshop in 2008, Advances in Urology symposium in 2008, Robotic Masterclass Workshop in 2010, Annual Scientific Meeting in 2013 and its Scientific Chairman in 2011.
Dr Sim was the chairman of the Singapore Prostate cancer management guidelines committee in 2012 and sits on the Asian advisory panel for the National Comprehensive Cancer Network Prostate cancer guidelines. He was a member of the Ministry of Health prostate cancer screening guidelines committee in 2008. He was also a panel member for the kidney cancer management guidelines at the Asian Oncology Summit in 2012. He has been invited as a speaker in Urology at several conferences in Southeast Asia, China and USA, and has mentored several generations of local urologists and overseas clinical fellows.